Trial Profile
Phase II trial testing ultra-fractionated brain irradiation + temozolomide for inoperable glioblastoma multiforme [Essai de phase II testant une association concomitante irradiation cerebrale ultra-fractionnee- temozolomide pour des glioblastomes multiformes inoperables de novo]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Acronyms TEMOFRAC
- 30 Aug 2011 New trial record